Universitätsklinikum Düsseldorf


The German Cancer Consortium (DKTK) Research Group (Head Dr. Marc Remke) at the Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich Heine University Düsseldorf is seeking a
Research Fellow/ Post-doc (Full-Time)
 for 3 years with possibility of prolongment.
The project “Unraveling medulloblastoma biology by proteogenomics” is focused on integrative analyses of genome- and proteome-wide alterations in primary medulloblastoma tissue samples. This tumor entity constitutes the most common malignant brain tumor in childhood. We aim to identify novel biomarkers to improve risk stratification in the context of established therapies and to develop novel molecular-based targeted therapies. Our research group “Pediatric Neuro-Oncogenomics” was recently established within the German Cancer Consortium (DKTK) and is affiliated with the German Cancer Research Center and the Heinrich-Heine University Düsseldorf.
Requirements: Doctoral degree in Medicine, Biology, Biochemistry or Molecular Biology, excellent experimental experience in tumor biology, (tumor) genomics / proteomics, neurobiology or cell biology and very good command of English. Desirable are experiences in bioinformatics and biostatistics.
We offer a stimulating scientific environment, a multidisciplinary team and a modern laboratory. We are actively involved with many established national and international collaborations.  
The application written in English or German should include an application letter, CV, university diploma and certificates, publication list, grants etc..
Questions concerning the application can be addressed to marc.remke@med.uni-duesseldorf.de / m.remke@dkfz.de.
The salary will be according to the provisions of the German collective labor agreement (TV-L up to EG 13).
The contract will be affiliated with University Hospital Düsseldorf.
Female candidates are encouraged to apply; they will be given preference in cases of equal aptitude, ability, and professional achievements unless there are exceptional reasons for choosing another applicant.
Applications from suitably qualified severely disabled persons or disabled persons regarded as being of equal status according to Book IX of the German Social Legal Code (SGB – Soziales Gesetzbuch) are encouraged to apply. Disabled applicants will be given preferential consideration in the case of equal aptitude.
For administrative reasons, we cannot return applications. In submitting your application, you give your consent to the retention of the application documents by the university hospital Düsseldorf. 
Applications comprising all relevant documents must be sent within 4 weeks of the publication of this announcement to
Universitätsklinikum Düsseldorf
D 01.2.1 – Kennziffer:  105E/15 , Moorenstr. 5, D-40225 Düsseldorf



Universitätsklinikum Düsseldorf
Moorenstr. 5
40225 Düsseldorf
Klinische Forschung
Forschung & Entwicklung
Forschung & Lehre
Klinik & Praxis
mehr als 500